# TechnoDerma Medicines

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/technoderma-medicines

- Industry: Biotechnology
- Headquarters: Chengdu, China
- Website: www.tkskin.com
- Latest round: Series A (Jan 13, 2023)
- Investors on record: 5

## About

Based in Jiaxing, China, and established in 2014, TechnoDerma Medicines Inc. previously known as Tekeluo Biology is a biotechnology company that engages in the research and development of small-molecule drugs for skin diseases. It has established partnerships with Precedo, Pharmaron, and so on.  Zengquan Wang, the company's founder, received his Ph.D. from Washington State University in the United States and worked in pharmaceutical corporations such as OSI Pharmaceutical, Pfizer, and AstraZeneca. In December 2023, the company completed Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis. In January 2024, TechnoDerma Medicines closed a pre-series B funding.

TechnoDerma Medicines Inc.'s R&D pipeline includes candidate drugs for hair loss, atopic dermatitis, psoriasis, and systemic lupus erythematosus (SLE). The company's candidate drug, TDM-105795, for the treatment of androgenetic alopecia(AGA), has been granted global intellectual property rights. The company is in R&D on a candidate drug for psoriasis and atopic dermatitis, which has entered the Chemistry and Manufacturing Controls (CMC) and preclinical stage. The atopic dermatitis program passed an Investigational new drug (IND) certification in July 2022 and is in phase I clinical trials.

The company will use the pre-series B funds for the clinical development of hair projects and China-US IIa clinical trials of eczema and dermatitis projects.

## Funding rounds

- Series A, Jan 13, 2023 — CDHT Hi-Tech Venture, BIO-TOWN Capital
- Series A, Apr 7, 2021 — CDH Investments, Oceanpine Capital, Linden Asset Group

## Investors

- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series A
- Oceanpine Capital (https://capitalatlas.ai/funds/oceanpine-capital) — Series A
- Linden Asset Group — Series A
- CDHT Hi-Tech Venture (https://capitalatlas.ai/funds/cdht-hi-tech-venture) — Series A
- BIO-TOWN Capital (https://capitalatlas.ai/funds/bio-town-capital) — Series A